Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors

Familial hypercholesterolaemia is an autosomal dominant inherited disorder characterised by elevated low-density lipoprotein cholesterol levels and consequently an increased risk of atherosclerotic cardiovascular disease (ASCVD). Familial hypercholesterolaemia is relatively common, but is often unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Pećin, Ivan, Hartgers, Merel L, Hovingh, G Kees, Dent, Ricardo, Reiner, Željko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
CVD Risk Factors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574519/
https://www.ncbi.nlm.nih.gov/pubmed/28644091
http://dx.doi.org/10.1177/2047487317717346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574519/
https://www.ncbi.nlm.nih.gov/pubmed/28644091
http://dx.doi.org/10.1177/2047487317717346

Ejemplares similares